⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Supplementary Figure S3 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer

View Full Paper

Ask AI

Bookmark

Share

Abstract

RAD51 expression and platinum chemotherapy response in vitro and in patient tumors

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Compadre et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522f71 https://doi.org/10.1158/1078-0432.27031120.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024
2Supplementary Figure S4 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024
3Supplementary Figure S4 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024
4Supplementary Figure S2 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024
5Supplementary Figure S2 from RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer2024